Taysha Gene Therapies Inc
NASDAQ:TSHA

Watchlist Manager
Taysha Gene Therapies Inc Logo
Taysha Gene Therapies Inc
NASDAQ:TSHA
Watchlist
Price: 1.79 USD 4.07% Market Closed
Market Cap: 367m USD

Relative Value

The Relative Value of one TSHA stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.79 USD, Taysha Gene Therapies Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TSHA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
10
vs Industry
27
Median 3Y
24.3
Median 5Y
2.2
Industry
7.3
Forward
63.7
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-3.6
Industry
21.6
Forward
-4.6
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-4.7
Industry
19.8
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-4.9
Industry
24.9
vs History
29
vs Industry
11
Median 3Y
4.3
Median 5Y
4.1
Industry
2.4
vs History
14
vs Industry
26
Median 3Y
14.7
Median 5Y
1.4
Industry
7.4
Forward
47.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.3
vs History
vs Industry
Median 3Y
-1.9
Median 5Y
-2.7
Industry
3.9
Forward
-2.8
vs History
vs Industry
Median 3Y
-1.9
Median 5Y
-3
Industry
3.7
Forward
-2.8
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-3.5
Industry
4.9
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-3.5
Industry
3.2
vs History
38
vs Industry
15
Median 3Y
8.4
Median 5Y
10.3
Industry
4.3

Multiples Across Competitors

TSHA Competitors Multiples
Taysha Gene Therapies Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Taysha Gene Therapies Inc
NASDAQ:TSHA
366.8m USD 44 -4.1 -3.2 -3.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 36 329 482 -172 668.6 -209 674.7 -207 282.1
US
Abbvie Inc
NYSE:ABBV
378.6B USD 6.7 89.3 17.4 26.3
US
Amgen Inc
NASDAQ:AMGN
170.3B USD 5.1 41.6 16.7 29.6
US
Gilead Sciences Inc
NASDAQ:GILD
140B USD 4.9 291.7 11.4 14.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
132B USD 12 -246.5 27 28.3
US
Epizyme Inc
F:EPE
94.1B EUR 1 939.2 -494.8 -538.8 -524.5
AU
CSL Ltd
ASX:CSL
120.6B AUD 5.1 28.1 17.3 21.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.4B USD 5.2 16.9 11.2 12.5
US
Seagen Inc
F:SGT
39.3B EUR 18.7 -57.3 -61.6 -55.6
NL
argenx SE
XBRU:ARGX
32.9B EUR 16.4 43.2 318.7 -2 348.3
P/S Multiple
Revenue Growth P/S to Growth
US
Taysha Gene Therapies Inc
NASDAQ:TSHA
Average P/S: 3 302 867.2
44
75%
0.6
FR
Pharnext SCA
OTC:PNEXF
36 329 482
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
8%
0.8
US
Amgen Inc
NASDAQ:AMGN
5.1
4%
1.3
US
Gilead Sciences Inc
NASDAQ:GILD
4.9
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
12
10%
1.2
US
E
Epizyme Inc
F:EPE
1 939.2
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.2
7%
0.7
US
S
Seagen Inc
F:SGT
18.7
30%
0.6
NL
argenx SE
XBRU:ARGX
16.4
37%
0.4
P/E Multiple
Earnings Growth PEG
US
Taysha Gene Therapies Inc
NASDAQ:TSHA
Average P/E: 85.1
Negative Multiple: -4.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -172 668.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
89.3
88%
1
US
Amgen Inc
NASDAQ:AMGN
41.6
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
291.7
185%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -246.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -494.8 N/A N/A
AU
CSL Ltd
ASX:CSL
28.1
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
11%
1.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.3 N/A N/A
NL
argenx SE
XBRU:ARGX
43.2
19%
2.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Taysha Gene Therapies Inc
NASDAQ:TSHA
Average EV/EBITDA: 60
Negative Multiple: -3.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -209 674.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
17.4
13%
1.3
US
Amgen Inc
NASDAQ:AMGN
16.7
14%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
11.4
6%
1.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27
16%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -538.8 N/A N/A
AU
CSL Ltd
ASX:CSL
17.3
12%
1.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.2
17%
0.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.6 N/A N/A
NL
argenx SE
XBRU:ARGX
318.7
168%
1.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Taysha Gene Therapies Inc
NASDAQ:TSHA
Average EV/EBIT: 22.1
Negative Multiple: -3.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -207 282.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
26.3
29%
0.9
US
Amgen Inc
NASDAQ:AMGN
29.6
31%
1
US
Gilead Sciences Inc
NASDAQ:GILD
14.3
10%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.3
15%
1.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -524.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.6
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
17%
0.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -2 348.3 N/A N/A